Hanse Service Internationale Pharmaceutical Import Profile — Germany (DGFT 2022–2026)

Name: Hanse Service Internationale Pharmaceutical Import Records from India — 2 Products, $1.9M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Hanse Service Internationale — Pharmaceutical Importer Profile (2026) | 2 Products, $1.9M Trade | TransData Nexus

Hanse Service Internationale

Pharmaceutical Importer · Germany · Antibiotics Focus · $1.9M Total Trade · DGFT Verified

Hanse Service Internationale is a pharmaceutical importer based in Germany with a total trade value of $1.9M across 2 products in 2 therapeutic categories. Based on 37 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Hanse Service Internationale sources from 2 verified Indian suppliers, with Gufic Biosciences Limited accounting for 89.6% of imports.

Hanse Service Internationale — Import Portfolio & Supplier Network

Hanse Service Internationale import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Hanse Service Internationale?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Gufic Biosciences Limited	$2.2M	51	89.6%
Ipca Laboratories Limited	$250.1K	10	10.4%

Hanse Service Internationale sources from 2 verified Indian suppliers across .

What Formulations Does Hanse Service Internationale Import?

Formulation	Value	Ships
Vancomycin dr. eberth 500MG	$555.9K	12
Vancomycin dr. eberth 1000MG	$550.0K	11
Harmless medicines hydroxychloroquinsul	$100.0K	4
Clarithromycin dr. eberth 500MG	$100.0K	2
Clarithromycin eberth 500 MG	$93.3K	2
Teicoplanin eberth 400 MG Pack size 1x1 s vls 24000	$50.0K	1
H.l. med.:hydroxychloroquinsulfat dr.	$50.0K	1
Harmless medicines hydroxychloroquinsulfate dr.eberth 200MG filmtabletten hydroxychloroquine*qty 22224	$50.0K	1
Harmless medicines: hydroxychloroquinsulfat dr.eberth 200MG	$50.0K	1
Vancomycin dr. eberth 1000MG (vancomycinhcl powder of INJ 1000 MG ) (Pack size-1x10?s 6076 packs, 60760 vials	$50.0K	1
Vancomycin dr. eberth 500MG (vancomycinhcl powder of INJ 500 MG) (Pack size-1x10?s,12315 packs, 123150 vials	$50.0K	1
Vancomycin 500MG Each vials contain 0.500 gram (vancomycin dr.eberth 500MG)(10366 Pack x 1x10 vials = 103660 vials)	$50.0K	1
Vancomycin 1000 MG Each vials contain 1.000 gram (vancomycin dr.eberth 1000MG)(8041 packs x 1x10 vials = 80410 vials)	$50.0K	1
Vancomycin 500MG Each vials contain 0.500 gram (vancomycin dr.eberth 500MG)(6185packx1x10 vials=61850vials)	$50.0K	1
Pharma: vancomycin dr.eberth 1000MG (vancomycin hcl powder of injection 1000MG)(4026 Pack x 1x10 vials = 40260 vials)	$50.0K	1

Hanse Service Internationale imports 34 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Vancomycin	Antibiotics	$1.7M	34	1.8%	8
2	Teicoplanin	Advanced Antibiotics	$150.0K	3	2.4%	3

Hanse Service Internationale imports 2 pharmaceutical products across 2 categories into Germany totaling $1.9M.

Hanse Service Internationale — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Hanse Service Internationale Fachspedition GmbH, established in 1983, is a Hamburg-based logistics company specializing in pharmaceutical and food industries. The company offers comprehensive services, including air and sea freight, warehousing, and specialized packaging solutions. In January 2025, Logwin acquired Hanse Service Internationale, enhancing its expertise in pharmaceutical and food logistics. (firmenpresse.de)

2Distribution Network

Hanse Service Internationale operates from two locations in Hamburg, Germany, encompassing a total of 7,600 m² of temperature-controlled storage space. The facilities are equipped with state-of-the-art warehouse management systems, ensuring efficient handling of pharmaceutical products. (firmenpresse.de)

3Industry Role

Hanse Service Internationale functions as a logistics service provider specializing in pharmaceutical and food industries. The company offers comprehensive services, including air and sea freight, warehousing, and specialized packaging solutions. (firmenpresse.de)

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Hanse Service Internationale

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Hanse Service Internationale's sourcing strategy is highly concentrated, with 100% of its pharmaceutical imports from India comprising only two products: Vancomycin and Teicoplanin. This single-source dependency may pose risks, such as supply chain disruptions or price fluctuations. The company's reliance on two suppliers—GUFIC BIOSCIENCES LIMITED and IPCA LABORATORIES LIMITED—suggests a stable relationship, but the lack of diversification could impact supply chain resilience.

2Supply Chain Resilience

The resilience of Hanse Service Internationale's Indian supply chain is limited due to its dependence on a narrow product range and a small number of suppliers. The absence of backup suppliers and limited formulation diversity heighten the risk of supply chain disruptions. Additionally, the company's exposure to specific shipping routes and reliance on a single source for both products further compromise supply chain stability.

3Strategic Implications

Hanse Service Internationale's concentrated sourcing strategy may limit its competitive position by exposing it to supply chain vulnerabilities. For Indian exporters, this presents an opportunity to diversify their product offerings and establish relationships with Hanse Service Internationale, potentially reducing the company's dependency on a limited supplier base.

Importing Pharmaceuticals into Germany — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Germany

1Regulatory Authority & Framework

In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) is the primary regulatory authority overseeing pharmaceutical imports. The German Medicines Act (Arzneimittelgesetz - AMG) governs the manufacturing, approval, dispensing, and importation of medicinal products. For Indian generics, obtaining a marketing authorization from BfArM is essential for importation into Germany. (zoll.de)

2Import Licensing & GMP

Importers of pharmaceuticals in Germany must hold a wholesale distribution authorization in accordance with Section 52a of the AMG. Additionally, Good Manufacturing Practice (GMP) certificates, such as EU GMP, WHO GMP, or PIC/S, are recognized and required for the importation of medicinal products. Compliance with these standards ensures the quality and safety of imported pharmaceuticals. (zoll.de)

3Quality & Labeling

Imported pharmaceutical products must undergo batch testing to verify quality and safety. Stability requirements ensure that products maintain their efficacy throughout their shelf life. Labeling must be in German and include essential information such as dosage, administration instructions, and storage conditions. Serialization mandates are in place to enhance traceability and prevent counterfeit products. (zoll.de)

Hanse Service Internationale — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Hanse Service Internationale's focus on importing Vancomycin and Teicoplanin suggests a strategic emphasis on antibiotics, particularly advanced antibiotics. This aligns with market demand for effective treatments against resistant bacterial infections. The company's portfolio concentration indicates a targeted approach to meet specific therapeutic needs.

2Sourcing Profile

Hanse Service Internationale's sourcing strategy is highly concentrated, importing only two pharmaceutical products from India. This limited diversification may expose the company to supply chain risks but also allows for specialized focus on these products. India's competitive pricing and established pharmaceutical manufacturing capabilities make it a strategic partner for such imports.

3Market Positioning

Based on its product mix, Hanse Service Internationale serves the wholesale distribution segment of the German pharmaceutical market. By focusing on specific antibiotics, the company positions itself as a specialized supplier catering to the needs of healthcare providers requiring these treatments.

Seller's Guide — How to Become a Supplier to Hanse Service Internationale

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Hanse Service Internationale by offering alternative products or formulations that complement the existing portfolio. Diversifying the product range could reduce the company's dependency on a limited number of suppliers and enhance supply chain resilience.

2Requirements & Qualifications

Indian exporters seeking to supply Hanse Service Internationale must obtain marketing authorization from BfArM and ensure compliance with EU GMP standards. Products must meet German labeling requirements, including German language labeling and serialization mandates. Adhering to these standards is crucial for successful market entry. (zoll.de)

3How to Approach

Indian exporters should initiate contact with Hanse Service Internationale by presenting their product portfolio and demonstrating compliance with German regulatory standards. Participating in relevant tenders and establishing a clear regulatory filing strategy will facilitate market entry. Understanding the company's specific needs and aligning offerings accordingly will enhance the potential for a successful partnership.

Frequently Asked Questions — Hanse Service Internationale

What products does Hanse Service Internationale import from India?

Hanse Service Internationale imports 2 pharmaceutical products across 2 categories. Top imports: Vancomycin ($1.7M), Teicoplanin ($150.0K).

Who supplies pharmaceuticals to Hanse Service Internationale from India?

Hanse Service Internationale sources from 2 verified Indian suppliers. The primary supplier is Gufic Biosciences Limited (89.6% of imports, $2.2M).

What is Hanse Service Internationale's total pharmaceutical import value?

Hanse Service Internationale's total pharmaceutical import value from India is $1.9M, based on 37 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Hanse Service Internationale focus on?

Hanse Service Internationale imports across 2 categories. The largest: Antibiotics (91.9%), Advanced Antibiotics (8.1%).

Get Full Hanse Service Internationale Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.